LakeShore Biopharma Co., Ltd.(LSB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LSB LakeShore Biopharma Co., Ltd.

Trading 10-23 12:21:30 EDT

2.97

+0.42

+16.47%

High3.28	Low2.62	Vol76.18K
Open3.19	D1 Closing2.55	Amplitude25.81%
Mkt Cap56.67M	Tradable Cap10.69M	Total Shares19.08M
T/O223.44K	T/O Rate2.12%	Tradable Shares3.60M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"LSB","market":"US","secType":"STK","nameCN":"LakeShore Biopharma Co., Ltd.","latestPrice":2.9701,"timestamp":1729700487886,"preClose":2.55,"halted":0,"volume":76179,"delay":0,"floatShares":3598541,"shares":19080751,"eps":-5.614551,"marketStatus":"Trading","change":0.4201,"latestTime":"10-23 12:21:30 EDT","open":3.19,"high":3.2784,"low":2.6202,"amount":223440.3658914,"amplitude":0.258118,"askPrice":3.18,"askSize":200,"bidPrice":2.84,"bidSize":20,"shortable":0,"etf":0,"ttmEps":-5.614551,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1729713600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":2.55,"preHourTrading":{"tag":"盘前","latestPrice":3.2,"preClose":2.55,"latestTime":"09:29 EDT","volume":12094,"amount":38003.139469,"timestamp":1729690162852},"postHourTrading":{"tag":"盘后","latestPrice":2.7058,"preClose":2.55,"latestTime":"19:07 EDT","volume":1668,"amount":4132.7881,"timestamp":1729638428839},"volumeRatio":3.866522},"requestUrl":"/m/hq/s/LSB","defaultTab":"news","newsList":[{"id":"2474679774","title":"LSB Industries, Inc. Schedules 2024 Third Quarter Financial Results Release for Tuesday, October 29th and Conference Call for Wednesday, October 30th","url":"https://stock-news.laohu8.com/highlight/detail?id=2474679774","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474679774?lang=en_us&edition=fundamental","pubTime":"2024-10-11 04:05","pubTimestamp":1728590700,"startTime":"0","endTime":"0","summary":"OKLAHOMA CITY, October 10, 2024----LSB Industries, Inc. , , today announced that it will release its financial results for the third quarter ended September 30, 2024 on Tuesday, October 29, 2024 after the close of the stock market.LSB’s management will host a conference call on Wednesday, October 30, 2024 at 10:00 am ET / 9:00 am CT to discuss these results. Participating in the call will be Chairman, President & Chief Executive Officer, Mark Behrman, Executive Vice President & Chief Financial Officer, Cheryl Maguire and Executive Vice President & Chief Commercial Officer, Damien Renwick. Interested parties may participate in the call by dialing  407-6176 /  689-8451. Please call in 10 minutes before the conference is scheduled to begin and ask for the LSB Industries conference call. Following the prepared remarks, there will be a question and answer session.Investor Contacts: Fred Buonocore, CFA, Vice President of Investor Relations 510-3550fbuonocore@lsbindustries.com Media Contact: ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fIwQjb48zNbS9ha_fEPA_g--~B/aD0yNTM7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/62d1b39ff7c04b0cf109b40dca22b47f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fIwQjb48zNbS9ha_fEPA_g--~B/aD0yNTM7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/62d1b39ff7c04b0cf109b40dca22b47f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lsb-industries-inc-schedules-2024-200500445.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LSB","LXU","BK4098","BK4139"],"gpt_icon":0},{"id":"2474778330","title":"LSB Industries Shares Surge After UBS Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2474778330","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474778330?lang=en_us&edition=fundamental","pubTime":"2024-10-11 02:28","pubTimestamp":1728584922,"startTime":"0","endTime":"0","summary":"LSB Industries  shares jumped nearly 15% in recent Thursday trading after UBS upgraded the company's stock to buy from neutral and adjusted the price target to $11 from $9.50.Trading volume stood at over 1 million shares against the daily average of about 338,000.Price: 9.60, Change: +1.25, Percent Change: +14.97","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LXU","LSB"],"gpt_icon":0},{"id":"2474499387","title":"LSB Industries rises 11.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474499387","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474499387?lang=en_us&edition=fundamental","pubTime":"2024-10-10 21:50","pubTimestamp":1728568220,"startTime":"0","endTime":"0","summary":"LSB Industries is up 11.5%, or 96c to $9.31. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lsb-industries-rises-11-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lsb-industries-rises-11-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LSB","BK4139"],"gpt_icon":0},{"id":"2474797817","title":"UBS Upgrades LSB Industries to Buy From Neutral, Adjusts Price Target to $11 From $9.50","url":"https://stock-news.laohu8.com/highlight/detail?id=2474797817","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474797817?lang=en_us&edition=fundamental","pubTime":"2024-10-10 17:50","pubTimestamp":1728553856,"startTime":"0","endTime":"0","summary":"LSB Industries (LXU) has an average outperform rating and a price target range of $8 to $15, according to analysts polled by Capital IQ.(MT Newswires covers equity, commodity and economic research fro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LXU","LSB"],"gpt_icon":0},{"id":"2474640135","title":"LakeShore Biopharma Shares Higher on Unchanged FY Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2474640135","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474640135?lang=en_us&edition=fundamental","pubTime":"2024-10-09 01:58","pubTimestamp":1728410280,"startTime":"0","endTime":"0","summary":"Shares of LakeShore Biopharma climbed after the company kept its outlook for fiscal 2025 unchanged following a 28% to 39% increase in revenue in the first half of the year.The stock was up 7.9% to $3.57 on Tuesday. Shares have, however, plunged 48% on a month-to-date basis.The developer and manufacturer of vaccines and other immune products said its performance during the first six months of the fiscal year ending March 31, 2025, demonstrated solid progress toward its full-year goals.For fiscal 2025, the company most recently guided for double-digit year-over-year revenue growth, and said it expected to achieve breakeven during the period.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LSB"],"gpt_icon":0},{"id":"2473478432","title":"LakeShore Biopharma Projects Strong Growth in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2473478432","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473478432?lang=en_us&edition=fundamental","pubTime":"2024-10-08 21:27","pubTimestamp":1728394055,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma (LSB) has released an update. LakeShore Biopharma has announced optimistic financial guidance for the first half of Fiscal Year...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lakeshore-biopharma-projects-strong-growth-in-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lakeshore-biopharma-projects-strong-growth-in-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LSB","BK4139"],"gpt_icon":0},{"id":"2473475627","title":"LakeShore Biopharma provides HY guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2473475627","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473475627?lang=en_us&edition=fundamental","pubTime":"2024-10-08 21:14","pubTimestamp":1728393249,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma  provided guidance for the half year of its fiscal year of 2025 and reaffirmed its guidance for FY 2025. LakeShore said it estimates its preliminary total revenue for the first six months in the range of RMB350M to RMB380M, representing growth of 28% to 39% from RMB273.1M in revenues during the same period, the previous year.  LakeShore Biopharma  said it has been pursuing strategic initiatives including cost reductions, organizational restructuring and management process enhancements to eliminate non-essential expenditures. The company’s shares rose 11% in premarket trading on Tuesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4156993-lakeshore-biopharma-provides-hy-guidance","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4139","LSB"],"gpt_icon":0},{"id":"2473421515","title":"Press Release: LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2473421515","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473421515?lang=en_us&edition=fundamental","pubTime":"2024-10-08 20:30","pubTimestamp":1728390600,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance. LakeShore Biopharma's previously issued guidance anticipated double-digit year-over-year revenue growth during Fiscal Year 2025 and noted that the Company expected to achieve breakeven during the period. The Company's performance in the first six months of its Fiscal Year 2025 has demonstrated solid progress towards these goals, with a preliminary total revenue estimate for the first six months in the range of RMB350 million to RMB380 million, representing substantial growth of 28% to 39% from RMB273.1 million in revenues during the same period in its fiscal year 2024.In addition to advancing its existing pipeline, LakeShore Biopharma has been vigorously pursuing strategic initiatives including cost reductions, organizational restructuring and optimization, and management process enhancements to boost operational efficiency and eliminate non-essential expenditures. F","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4022","BK4232","LSB","BK4139"],"gpt_icon":0},{"id":"2473216632","title":"LSB Industries (NYSE:LXU) shareholders have earned a 16% CAGR over the last five years","url":"https://stock-news.laohu8.com/highlight/detail?id=2473216632","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473216632?lang=en_us&edition=fundamental","pubTime":"2024-10-06 20:41","pubTimestamp":1728218509,"startTime":"0","endTime":"0","summary":"The most you can lose on any stock  is 100% of your money. But on the bright side, if you buy shares in a high quality company at the right price, you can gain well over 100%. Long term LSB Industries, Inc.  shareholders would be well aware of this, since the stock is up 107% in five years. It's also up 19% in about a month.So let's assess the underlying fundamentals over the last 5 years and see if they've moved in lock-step with shareholder returns.Given that LSB Industries only made minimal earnings in the last twelve months, we'll focus on revenue to gauge its business development. As a general rule, we think this kind of company is more comparable to loss-making stocks, since the actual profit is so low. It would be hard to believe in a more profitable future without growing revenues.Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/53DNnDwGQ.sWa.kpiAGkDg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/800971adf439bdcde1db382e07278edb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/53DNnDwGQ.sWa.kpiAGkDg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/800971adf439bdcde1db382e07278edb"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lsb-industries-nyse-lxu-shareholders-124149752.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NYSE","BK4098","LSB","LXU","BK4139"],"gpt_icon":0},{"id":"2472219603","title":"Upcoming Stock Splits This Week (September 30 to October 4) – Stay Invested","url":"https://stock-news.laohu8.com/highlight/detail?id=2472219603","media":"TipRanks","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472219603?lang=en_us&edition=fundamental","pubTime":"2024-10-01 19:35","pubTimestamp":1727782516,"startTime":"0","endTime":"0","summary":"These are the upcoming stock splits for the week of September 30 to October 4, based onTipRanks’ Stock Splits Calendar. A stock split is a corporate action in which the company issues additional common shares to increase the number of outstanding shares. Accordingly, the stock price of the company’s shares decreases, which maintains the market capitalization before and after the split.In contrast, there are also reverse stock splits that reduce the number of outstanding shares . In this case, too, the market cap is maintained as the share price increases following the reverse stock split.Companies often undertake stock splits to improve the liquidity of the common shares and make them more affordable for retail investors. Let’s look quickly at the upcoming stock splits for the week.Sonnet Biotherapeutics  – Sonnet Biotherapeutics is a clinical-stage biotechnology company that fo","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_ETHa7I7Z0cqPJo4k6Xn2w--~B/aD04NTM7dz05NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/cf7fd41cd48ad347b8942b84baa25739","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_ETHa7I7Z0cqPJo4k6Xn2w--~B/aD04NTM7dz05NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/cf7fd41cd48ad347b8942b84baa25739"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/upcoming-stock-splits-week-september-113516762.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/upcoming-stock-splits-week-september-113516762.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0004445015.USD","BK4077","KRKR","LU0444971666.USD","IE00B7KXQ091.USD","IE00BJJMRY28.SGD","NDEKY","CNET","LRCX","CAULF","SMCI","STRM","BK4566","IE00BJJMRX11.SGD","BWNAF","LU1815333072.USD","LU1670627923.USD","BTKRF","SONN","EP","IE00BQXX3D17.EUR","BJURF","AGBA","LU1035773651.USD","LXEH","IE00B775H168.HKD","SIFY","SOMLY","LU2023250504.SGD","IE0005OL40V9.USD","LU2106854487.HKD","GHVNF","LSB","LU0648000940.SGD","BK4588","BK4139","LU1815336760.USD","AUKUF","IE00B4JS1V06.HKD","RYAAY","BDRX","BK4170","LU0096362180.USD","LU1861220033.SGD","BK4213","LU0082616367.USD","LU1917777945.USD","ADTX","LU0053671581.USD","IE00BQXX3C00.GBP"],"gpt_icon":1},{"id":"2470570288","title":"LakeShore Biopharma Updates Corporate Framework","url":"https://stock-news.laohu8.com/highlight/detail?id=2470570288","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470570288?lang=en_us&edition=fundamental","pubTime":"2024-09-27 19:44","pubTimestamp":1727437444,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma (LSB) has released an update. LakeShore Biopharma Co., Ltd has announced an update to its corporate structure with a Second Ame...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lakeshore-biopharma-updates-corporate-framework?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lakeshore-biopharma-updates-corporate-framework?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LSB","BK4139"],"gpt_icon":0},{"id":"2470091357","title":"LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation","url":"https://stock-news.laohu8.com/highlight/detail?id=2470091357","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470091357?lang=en_us&edition=fundamental","pubTime":"2024-09-27 19:00","pubTimestamp":1727434800,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., Sept. 27, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd  , a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the results of its extraordinary general meeting  held on September 27, 2024  virtually via a Zoom video conference call. The EGM was called as part of the Company's efforts to regain compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5450.The Company's shareholders voted in favor of each of the following resolutions:. With effect from October 1, 2024, to consolidate every 10  ordinary shares, par value of US$0.00002 each , into 1  ordinary share, par value of US$0.0002 each , such that following the Share Consolidation, the authorized share capital of the Company shall be changed. LakeShore Biopharma, previously known as YS Biopharma, is a global biopharmaceutical ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fgOh2Bycrm6QOb54aRCNmQ--~B/aD0xNjY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f5097b79ea5867061d136b5b68b78213","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fgOh2Bycrm6QOb54aRCNmQ--~B/aD0xNjY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f5097b79ea5867061d136b5b68b78213"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/lakeshore-biopharma-announces-results-extraordinary-110000658.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lakeshore-biopharma-announces-results-extraordinary-110000658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LSB","BK4139","LSBPW"],"gpt_icon":0},{"id":"2466458544","title":"LakeShore Biopharma Calls for Shareholder Vote on Stock Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2466458544","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466458544?lang=en_us&edition=fundamental","pubTime":"2024-09-10 20:50","pubTimestamp":1725972650,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma (LSB) has released an update. LakeShore Biopharma has announced an extraordinary general meeting (EGM) for shareholders on Sept...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lakeshore-biopharma-calls-for-shareholder-vote-on-stock-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lakeshore-biopharma-calls-for-shareholder-vote-on-stock-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LSB","BK4139"],"gpt_icon":0},{"id":"2466432364","title":"Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2466432364","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466432364?lang=en_us&edition=fundamental","pubTime":"2024-09-10 20:00","pubTimestamp":1725969600,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., Sept. 10, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd  , a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it will hold an extraordinary general meeting of shareholders  at 10:00 a.m., Beijing time, on September 27, 2024, virtually via a Zoom video conference call, for the purpose of considering and, if thought fit, passing the proposed resolutions set forth in the notice of EGM .Instructions for accessing the video conference call are as follows:","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/q_ZAlogtqanEC7UqKoPQ6A--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/4887634f19ef9c2d79fb5b31c20aa2bd","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/q_ZAlogtqanEC7UqKoPQ6A--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/4887634f19ef9c2d79fb5b31c20aa2bd"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/lakeshore-biopharma-hold-extraordinary-general-120000734.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lakeshore-biopharma-hold-extraordinary-general-120000734.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LSBPW","BK4139","LBBB","LSB"],"gpt_icon":0},{"id":"2466511822","title":"Update: TransUnion, 6 Other Public Companies Fined by SEC for Whistleblower Violations","url":"https://stock-news.laohu8.com/highlight/detail?id=2466511822","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466511822?lang=en_us&edition=fundamental","pubTime":"2024-09-10 00:57","pubTimestamp":1725901031,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["LU1543694498.USD","BK4094","LXU","BK4122","BK4139","IEX","LU1596574779.USD","LU1620156213.USD","LU1721428933.USD","BK4585","LU1989764664.SGD","BK4561","LU2125910336.SGD","ACHC","BK4588","SMFL","MT","LU1169590202.USD","BK4183","BK4123","BK4149","BK4023","LU1923621640.USD","BK4006","LU2413665964.HKD","BK4185","BK7007","SGXZ23171101.USD","LU2125910179.SGD","LU1620156130.USD","LU1989764748.USD","AKA","BK4161","IDEX","LU1721427968.SGD","LSB","BK4098","LU1169589451.USD","LU1165135440.EUR","SG9999004303.SGD","TRU","TRU.AU","APPF","LU2413666004.HKD"],"gpt_icon":0},{"id":"2466967801","title":"TransUnion, 6 Other Public Companies Fined by SEC for Whistleblower Violations","url":"https://stock-news.laohu8.com/highlight/detail?id=2466967801","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466967801?lang=en_us&edition=fundamental","pubTime":"2024-09-09 22:38","pubTimestamp":1725892722,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["LU1596574779.USD","BK4123","IEX","BK4023","BK4149","LU1169590202.USD","LU2125910336.SGD","LU1169589451.USD","LU1543694498.USD","LU2413666004.HKD","BK4185","LU1620156213.USD","BK4098","BK7007","LU1620156130.USD","LU1989764748.USD","BK4183","LU2413665964.HKD","BK4094","BK4161","AKA","SG9999004303.SGD","IDEX","BK4122","BK4585","BK4139","BK4561","LU1721427968.SGD","LU1923621640.USD","LU1721428933.USD","TRU","APPF","BK4588","SGXZ23171101.USD","SMFL","MT","LU1165135440.EUR","LXU","ACHC","BK4006","LSB","TRU.AU","LU1989764664.SGD","LU2125910179.SGD"],"gpt_icon":0},{"id":"2466816594","title":"LSB Industries (NYSE:LXU) Might Have The Makings Of A Multi-Bagger","url":"https://stock-news.laohu8.com/highlight/detail?id=2466816594","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466816594?lang=en_us&edition=fundamental","pubTime":"2024-09-09 18:59","pubTimestamp":1725879564,"startTime":"0","endTime":"0","summary":"Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that capital are also increasing. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. So when we looked at LSB Industries  and its trend of ROCE, we really liked what we saw.Return On Capital Employed : What Is It?For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. To calculate this metric for LSB Industries, this is the formula:. Above you can see how the current ROCE for LSB Industries compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like to see what analysts are forecasting going forward,","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/53DNnDwGQ.sWa.kpiAGkDg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/800971adf439bdcde1db382e07278edb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/53DNnDwGQ.sWa.kpiAGkDg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/800971adf439bdcde1db382e07278edb"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lsb-industries-nyse-lxu-might-105924022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LXU","LSB","BK4098","BK4139","EBIT","NYSE"],"gpt_icon":0},{"id":"2464599374","title":"LakeShore Biopharma Unveils Top Management Reshuffle","url":"https://stock-news.laohu8.com/highlight/detail?id=2464599374","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464599374?lang=en_us&edition=fundamental","pubTime":"2024-09-04 20:27","pubTimestamp":1725452871,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma (LSB) has released an update. LakeShore Biopharma has announced significant leadership changes, appointing Xu Wang as the new C...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lakeshore-biopharma-unveils-top-management-reshuffle?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lakeshore-biopharma-unveils-top-management-reshuffle?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LSB","BK4139"],"gpt_icon":0},{"id":"2464372506","title":"LakeShore Biopharma appoints Wang as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2464372506","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464372506?lang=en_us&edition=fundamental","pubTime":"2024-09-04 20:18","pubTimestamp":1725452297,"startTime":"0","endTime":"0","summary":"LakeShore Biopharma  said it has appointed Xu Wang as the chief executive officer.Wang will succeed Dave Chenn and Hui Shao, who step down from the role of interim CEO and co-CEO, respectively.Wang had been the firm's COO since June, but will step down from the role as he becomes CEO.The firm has also appointedRachel Yu to CFO from the role of interim finance chief.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4146682-lakeshore-biopharma-appoints-wang-as-ceo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4139","LSB"],"gpt_icon":0},{"id":"2464379500","title":"Press Release: LakeShore Biopharma Announces Leadership Transitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2464379500","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464379500?lang=en_us&edition=fundamental","pubTime":"2024-09-04 20:00","pubTimestamp":1725451200,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., Sept. 4, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd.  , a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that the board of directors of the Company  has appointed Mr. Xu Wang as the Chief Executive Officer of the Company. He succeeds Mr. Dave Chenn and Dr. Hui Shao, who step down from the Company's Interim Chief Executive Officer and Co-Chief Executive Officer position, respectively. Mr. Xu Wang has served as the Company's Chief Operation Officer since June 2024, and he will no longer assume such role upon becoming the Chief Executive Officer of the Company.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4232","LSB","BK4022","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ysbiopharma.com","stockEarnings":[{"period":"1week","weight":-0.3254},{"period":"1month","weight":-0.6688},{"period":"3month","weight":-0.4688},{"period":"6month","weight":-0.6792},{"period":"1year","weight":-0.582},{"period":"ytd","weight":-0.501}],"compareEarnings":[{"period":"1week","weight":0.0061},{"period":"1month","weight":0.0265},{"period":"3month","weight":0.0778},{"period":"6month","weight":0.1586},{"period":"1year","weight":0.3873},{"period":"ytd","weight":0.2272}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.","exchange":"NASDAQ","name":"LakeShore Biopharma Co., Ltd.","nameEN":"LakeShore Biopharma Co., Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.0","shortVersion":"4.29.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LakeShore Biopharma Co., Ltd.(LSB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LakeShore Biopharma Co., Ltd.(LSB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LakeShore Biopharma Co., Ltd.,LSB,LakeShore Biopharma Co., Ltd.股票,LakeShore Biopharma Co., Ltd.股票老虎,LakeShore Biopharma Co., Ltd.股票老虎国际,LakeShore Biopharma Co., Ltd.行情,LakeShore Biopharma Co., Ltd.股票行情,LakeShore Biopharma Co., Ltd.股价,LakeShore Biopharma Co., Ltd.股市,LakeShore Biopharma Co., Ltd.股票价格,LakeShore Biopharma Co., Ltd.股票交易,LakeShore Biopharma Co., Ltd.股票购买,LakeShore Biopharma Co., Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LakeShore Biopharma Co., Ltd.(LSB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LakeShore Biopharma Co., Ltd.(LSB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction